These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11105)

  • 41. [Structure-activity relationship of phenoxyalkanolamine derivatives with selective beta 1-receptor blocking action].
    Femmer K
    Pharmazie; 1975 Oct; 30(10):638-42. PubMed ID: 687
    [No Abstract]   [Full Text] [Related]  

  • 42. Anti-arrhythmic, local anaesthetic, and adrenergic blocking activity of some beta-receptor antagonists.
    Hermansen K
    Br J Pharmacol; 1969 Mar; 35(3):476-86. PubMed ID: 5809739
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies on a new 1,5-benzothiazepine derivative (CRD-401). V. Antiarrhythmic actions.
    Yamada K; Shimamura T; Nakajima H
    Jpn J Pharmacol; 1973 Jun; 23(3):321-8. PubMed ID: 4146776
    [No Abstract]   [Full Text] [Related]  

  • 44. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
    Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
    Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Beta-adrenoceptor studies. 2. Effects of alkyl substitution on beta-adrenoceptor blocking, antiarrhythmic, and local anesthetic activities of 1,1'-(o-phenylenedioxy)bis(3-isopropylamino-2-propanol).
    Zaagsma J; Nauta WT
    J Med Chem; 1977 Apr; 20(4):527-31. PubMed ID: 15113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent.
    Miyagishi A; Nakahara H; Hara Y
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):249-62. PubMed ID: 6210068
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increase of the ventricular fibrillation threshold by 711389-S, a new antiarrhythmic agent, in guinea-pigs.
    Nakajima S; Ueda M
    Jpn J Pharmacol; 1985 Aug; 38(4):436-8. PubMed ID: 3840850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beta receptor blocking and antiarrhythmic properties of tolamolol.
    Bagwell EE; Custy J; Steen RG; Newman WH
    J Pharmacol Exp Ther; 1974 Dec; 191(3):496-505. PubMed ID: 4154378
    [No Abstract]   [Full Text] [Related]  

  • 49. Pharmacological properties of new 1,2-benzisothiazolyloxypropanolamines on cardiac and tracheal beta-receptors.
    Barocelli E; Chiavarini M; Ballabeni V; Mingiardi MR; Morini G; Ronchini F; Impicciatore M
    Boll Soc Ital Biol Sper; 1992 Jul; 68(7):445-51. PubMed ID: 1362354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaninolol: a new selective beta 1-adrenoceptor antagonist derived from vanillin.
    Wu BN; Hwang TL; Liao CF; Chen IJ
    Biochem Pharmacol; 1994 Jul; 48(1):101-9. PubMed ID: 8043010
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Propranolol analog with the natural monoterpene structure as a potent antiarrhythmic drug.
    Librowski T; Filipek B; Czarnecki R; Beresewicz A; Karwatowska-Prokopczuk E
    Acta Pol Pharm; 1998; 55(3):243-7. PubMed ID: 9735705
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacologic evaluation of CI-775, a cardioselective beta adrenergic antagonist.
    Hastings SG; Smith RD; Corey RM; Essenburg AD; Pettway CE; Tessman DK
    Arch Int Pharmacodyn Ther; 1977 Mar; 226(1):81-99. PubMed ID: 17372
    [No Abstract]   [Full Text] [Related]  

  • 53. [Selectivity of beta-adrenergic compounds. IV. Studies on 1-(4'-methylphenyl)-2-isopropylaminopropanol].
    Lucchelli A; Grana E; Zonta F
    Farmaco Sci; 1977 Jun; 32(6):438-44. PubMed ID: 872923
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of beta-adrenergic blockers on Na(+)-K(+)-ATPase activity in guinea-pig heart preparations: comparison with ouabain.
    Almotrefi AA; Dzimiri N
    Arch Int Pharmacodyn Ther; 1991; 310():94-101. PubMed ID: 1685314
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electrophysiological characteristics of tobanum, a new beta receptor blocking agent.
    Solti F; Czakó E
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):229-32. PubMed ID: 6104635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of sympathetic nervous system by mexiletine, an antiarrhythmic agent, and its antagonism against ouabain.
    Kitagawa H; Takeda F; Kohei H
    Arzneimittelforschung; 1985; 35(1A):356-9. PubMed ID: 4039173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of beta-adrenoceptor agonists on KCl-induced rhythmic contraction in the ureter of guinea pig.
    Yamamoto Y; Koike K
    J Smooth Muscle Res; 2000 Feb; 36(1):13-9. PubMed ID: 10830474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of the anti-arrhythmic actions of I.C.I. 50172 and (--)-propranolol and their effects on intracellular cardiac action potentials and other features of cardiac function.
    Papp JG; Williams EM
    Br J Pharmacol; 1969 Oct; 37(2):391-9. PubMed ID: 4390670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative relationship between beta-adrenergic receptor number and physiologic responses as studied with a long-lasting beta-adrenergic antagonist.
    Terasaki WL; Linden J; Brooker G
    Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6401-5. PubMed ID: 42915
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the antifibrillatory activity of fluorinated derivatives of indenolol and nadolol in isolated rabbit and rat hearts: comparison with propranolol.
    Almotrefi AA; Aboul-Enein HY; Premkumar LS
    Arch Int Pharmacodyn Ther; 1989; 301():122-30. PubMed ID: 2576192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.